Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients

Archives of Ophthalmology

Volumn 128, Issue 2, 2010, Pages 206-210

  Hara, Ryuhei ^a   Kawaji, Takahiro ^a   Ando, Eiko ^a   Ohya, Yuki ^a   Ando, Yukio ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; METHIONINE; PREALBUMIN; VALINE;

ADULT; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; HUMAN TISSUE; JAPANESE; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; OCULAR AMYLOIDOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUPIL DISEASE; RETROSPECTIVE STUDY; RISK; VITRECTOMY; VITREOUS OPACITY;

ADULT; AGE OF ONSET; AGED; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRIS DISEASES; JAPAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREALBUMIN; RETROSPECTIVE STUDIES; VITREOUS BODY;

EID: 76349115825     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.390     Document Type: Article

References (20)

1. Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev. 1984;6(2):128-133.
2. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol. 2005;62(7):1057-1062.
3. Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993;341(8853):1113-1116.
4. Ando Y, Tanaka Y, Ando E, et al. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet. 1995;345(8943): 195-196.
5. Munar-Qués M, Salva-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraiva MJ. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid. 2000;7(4):266-269.
6. Ando E, Ando Y, Haraoka K. Ocular amyloid involvement after liver transplantation for polyneuropathy. Ann Intern Med. 2001;135(10):931-932.
7. Cavallaro T, Martone RL, Dwork AJ, Schon EA, Herbert J. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci. 1990;31(3):497-501.
8. Kawaji T, Ando Y, Nakamura M, et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res. 2005;81(3):306-312.
9. Haraoka K, Ando Y, Ando E, et al. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid. 2002;9(4):247-251.
10. Ando Y, Terazaki H, Nakamura M, et al. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation. 2004;77(3):345-349.
11. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol. 1995;40(3):173-196.
12. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol. 1997;81(4):295-298.
13. Koga T, Ando E, Hirata A, et al. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol. 2003; 135(2):188-193.
14. Kimura A, Ando E, Fukushima M, et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch Ophthalmol. 2003;121(3):351-356.
15. Takei Y, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Ando Y; Japanese Liver Transplantation Society. Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations. Intern Med. 2005;44(11):1151-1156.
16. Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol. 2008;86(5): 520-524.
17. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered. 1993;43(5):288-294.
18. Hammarström P, Schneider F, Kelly JW. Trans-suppression of misfolding in an amyloid disease. Science. 2001;293(5539):2459-2462.
19. Soares ML, Coelho T, Sousa A, et al. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden. Eur J Hum Genet. 2004;12(3):225-237.
20. Soares ML, Coelho T, Sousa A, et al. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a singlegene disease. Hum Mol Genet. 2005;14(4):543-553.